2003
DOI: 10.1016/j.biochi.2003.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Cell death and inflammation during infection with the obligate intracellular pathogen, Chlamydia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
25
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 28 publications
(25 citation statements)
references
References 61 publications
0
25
0
Order By: Relevance
“…In contrast, other groups have reported that C. pneumoniae, C. trachomatis, and C. psittaci stimulate cell death in epithelial cells, macrophages, and other cell types (16,35,(37)(38)(39)43). Furthermore, other types of obligate intracellular gram-negative bacteria, such as Legionella longbeachae, have been shown to induce apoptosis in macrophages (34).…”
Section: Discussionmentioning
confidence: 95%
“…In contrast, other groups have reported that C. pneumoniae, C. trachomatis, and C. psittaci stimulate cell death in epithelial cells, macrophages, and other cell types (16,35,(37)(38)(39)43). Furthermore, other types of obligate intracellular gram-negative bacteria, such as Legionella longbeachae, have been shown to induce apoptosis in macrophages (34).…”
Section: Discussionmentioning
confidence: 95%
“…Viruses and other obligate intracellular pathogens, such as Chlamydia sp. (45), have presumably evolved under considerable selective pressure to modulate apoptotic pathways, because premature death of the host cell would prevent the completion of their replication cycle. However, in some situations, such as virus egress, apoptosis may be beneficial, and many viruses have also evolved pro-apoptotic mechanisms (43).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, circumstantial evidence indicates that mTORC1 inhibition may have additional beneficial effects in AIDS patients by limiting the replication of HIV and the detrimental effects of the virus on the target CD4 ϩ T lymphocytes by preventing cell syncytium formation and p53-triggered cell apoptosis. 46,47 Finally, the application of mTORC1 inhibitors to treat ARL would represent an alternative to the current regimens of multi-agent chemotherapy which not only display a plethora of severe toxicities, but are also rather ineffective in the AIDS patients, 48,49 even when combined with an anti-CD20 antibody. 48 …”
Section: Discussionmentioning
confidence: 99%